Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
45.69 (1y: +15%)
Market Cap 4.51 B P/E(ttm) 18.80
Enterprise Value 5.42 B P/B 5.20
GNC- NYSE (USA)
GNC Acquisition Holdings Inc
Not Rated
Top Ranked Predictable Companies
$45.69
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry		 vs
history
Cash to Debt 0.144
GNC's Cash to Debt is ranked lower than
83% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.55 vs. GNC: 0.144 )
GNC' s 10-Year Cash to Debt Range
Min: 0.04   Max: 0.18
Current: 0.14
0.04
0.18
Equity to Asset -0.243
GNC's Equity to Asset is ranked lower than
96% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.34 vs. GNC: -0.243 )
GNC' s 10-Year Equity to Asset Range
Min: -0.36   Max: -0.02
Current: -0.24
-0.36
-0.02
Interest Coverage 9
GNC's Interest Coverage is ranked lower than
66% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 41.95 vs. GNC: 9 )
GNC' s 10-Year Interest Coverage Range
Min: 2   Max: 9
Current: 9
2
9
Z-Score: 3.53
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry		 vs
history
Operating margin (%) 17.60
GNC's Operating margin (%) is ranked higher than
97% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.80 vs. GNC: 17.60 )
GNC' s 10-Year Operating margin (%) Range
Min: 10.2   Max: 17.6
Current: 17.6
10.2
17.6
Net-margin (%) 9.9
GNC's Net-margin (%) is ranked higher than
94% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.50 vs. GNC: 9.9 )
GNC' s 10-Year Net-margin (%) Range
Min: 3.3   Max: 9.9
Current: 9.9
3.3
9.9
ROE (%) 27.2
GNC's ROE (%) is ranked higher than
91% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 8.80 vs. GNC: 27.2 )
GNC' s 10-Year ROE (%) Range
Min: 8.4   Max: 27.2
Current: 27.2
8.4
27.2
ROA (%) 9.4
GNC's ROA (%) is ranked higher than
90% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.20 vs. GNC: 9.4 )
GNC' s 10-Year ROA (%) Range
Min: 2.4   Max: 9.4
Current: 9.4
2.4
9.4
ROC (Joel Greenblatt) (%) 69.20
GNC's ROC (Joel Greenblatt) (%) is ranked higher than
90% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 16.00 vs. GNC: 69.20 )
GNC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 35.2   Max: 69.2
Current: 69.2
35.2
69.2
ยป GNC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

GNC Guru Trades in Q2 2012

Jim Simons 141,200 sh (New)
Paul Tudor Jones 590,800 sh (New)
Pioneer Investments 77,000 sh (+321.41%)
Columbia Wanger 2,396,600 sh (+53.48%)
Chuck Royce Sold Out
Louis Moore Bacon 341,875 sh (-55.02%)
Steven Cohen 1,142,254 sh (-69.77%)
» More
Q3 2012

GNC Guru Trades in Q3 2012

RS Investment Management 72,700 sh (New)
Bruce Kovner 13,200 sh (New)
Joel Greenblatt 22,100 sh (New)
Pioneer Investments 77,000 sh (unchged)
Columbia Wanger 2,355,200 sh (-1.73%)
Louis Moore Bacon 300,000 sh (-12.25%)
Steven Cohen 937,175 sh (-17.95%)
Jim Simons 93,000 sh (-34.14%)
Paul Tudor Jones 8,700 sh (-98.53%)
» More
Q4 2012

GNC Guru Trades in Q4 2012

Jim Simons 672,100 sh (+622.69%)
Joel Greenblatt 51,943 sh (+135.04%)
Columbia Wanger 2,461,900 sh (+4.53%)
RS Investment Management 75,100 sh (+3.3%)
Louis Moore Bacon Sold Out
Pioneer Investments 65,600 sh (-14.81%)
Paul Tudor Jones 7,000 sh (-19.54%)
Bruce Kovner 9,000 sh (-31.82%)
Steven Cohen 169,075 sh (-81.96%)
» More
Q1 2013

GNC Guru Trades in Q1 2013

Louis Moore Bacon 222,725 sh (New)
Mario Gabelli 5,400 sh (New)
Steven Cohen 4,276,960 sh (+2429.62%)
RS Investment Management 1,042,720 sh (+1288.44%)
Bruce Kovner 30,000 sh (+233.33%)
Joel Greenblatt 100,048 sh (+92.61%)
Jim Simons 989,700 sh (+47.25%)
Columbia Wanger 2,569,200 sh (+4.36%)
Pioneer Investments Sold Out
Paul Tudor Jones 5,500 sh (-21.43%)
» More
» Details

Insider Trades

Latest Guru Trades with GNC

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-03-31 Add 92.61%0.1%$32.2 - $42.19 $ 45.6521%100048
Mario Gabelli 2013-03-31 New Buy$32.2 - $42.19 $ 45.6521%5400
Joel Greenblatt 2012-12-31 Add 135.04%0.06%$32.6 - $40.72 $ 45.6526%51943
Joel Greenblatt 2012-09-30 New Buy0.06%$35.74 - $42.41 $ 45.6518%22100
Premium More recent guru trades are included for Premium Members only!!

Top Ranked Articles about GNC Acquisition Holdings Inc

President and CEO of GNC Holdings Inc. Joe Fortunato Sold 50,000 Shares
August 8, 2012
GNC Holdings Inc. operates as a specialty retailer of nutritional products including vitamin, mineral, herbal and other specialty supplements and sports nutrition, diet and energy products. GNC Holdings Inc. has a market cap of $4.18 billion; its shares were traded at around $39.06 with a P/E ratio of 19.3 and P/S ratio of 2. The dividend yield of GNC Holdings Inc. stocks is 1.1%. Read more...

Ratios

vs
industry		 vs
history
P/E(ttm) 18.90
GNC's P/E(ttm) is ranked higher than
78% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 16.24 vs. GNC: 18.90 )
GNC' s 10-Year P/E(ttm) Range
Min: 14.27   Max: 63
Current: 18.9
14.27
63
P/B 5.10
GNC's P/B is ranked lower than
83% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.51 vs. GNC: 5.10 )
GNC' s 10-Year P/B Range
Min: 2.22   Max: 5.17
Current: 5.1
2.22
5.17
P/S 1.90
GNC's P/S is ranked lower than
91% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.30 vs. GNC: 1.90 )
GNC' s 10-Year P/S Range
Min: 1.3   Max: 2.4
Current: 1.9
1.3
2.4
PFCF 22.80
GNC's PFCF is ranked lower than
72% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 14.04 vs. GNC: 22.80 )
GNC' s 10-Year PFCF Range
Min: 16.63   Max: 36.52
Current: 22.8
16.63
36.52
EV-to-EBIT 12.2
GNC's EV-to-EBIT is ranked higher than
76% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 11.60 vs. GNC: 12.2 )
GNC' s 10-Year EV-to-EBIT Range
Min: 9.8   Max: 15.2
Current: 12.2
9.8
15.2

Dividend & Buy Back

vs
industry		 vs
history
Dividend Yield 1.05
GNC's Dividend Yield is ranked higher than
50% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.82 vs. GNC: 1.05 )
GNC' s 10-Year Dividend Yield Range
Min: 0.27   Max: 1.35
Current: 1.05
0.27
1.35
Dividend Payout 0.1985
GNC's Dividend Payout is ranked higher than
92% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.52 vs. GNC: 0.1985 )
GNC' s 10-Year Dividend Payout Range
Min: 0.19   Max: 0.19
Current: 0.2
Yield on cost (5-Year) 1.10
GNC's Yield on cost (5-Year) is ranked lower than
52% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.91 vs. GNC: 1.10 )
GNC' s 10-Year Yield on cost (5-Year) Range
Min: 0.27   Max: 1.35
Current: 1.1
0.27
1.35

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 13.8
GNC's Price/Net Current Asset Value is ranked higher than
93% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.75 vs. GNC: 13.8 )
GNC' s 10-Year Price/Net Current Asset Value Range
Min: 10.5   Max: 10.6
Current: 13.8
10.5
10.6
Price/Median PS Value 1.1
GNC's Price/Median PS Value is ranked higher than
85% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.95 vs. GNC: 1.1 )
GNC' s 10-Year Price/Median PS Value Range
Min: 0.8   Max: 0.8
Current: 1.1
Earnings Yield (Greenblatt) 8.20
GNC's Earnings Yield (Greenblatt) is ranked higher than
81% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 9.30 vs. GNC: 8.20 )
GNC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 6.6   Max: 10.2
Current: 8.2
6.6
10.2

Business Description

GNC Acquisition Holdings Inc was formed as a Delaware corporation in November 2006. The Company is a global specialty retailer of health and wellness products, including VMHS products, sports nutrition products, and diet products. Its diversified, multi-channel business model derives revenue from product sales through domestic company-owned retail stores, domestic and international franchise activities, third-party contract manufacturing, e-commerce and corporate partnerships. The Company operates within the large and growing U.S. nutritional supplements industry. The Company generates revenues from its three business segments, Retail, Franchise, and Manufacturing/Wholesale. Its Retail segment generates revenues primarily from sales of products to customers at its company-owned stores in the United States and Canada. Its Franchise segment is comprised of its domestic and international franchise operations. Its Franchise segment generates revenues from franchise activities primarily through product sales to franchisees, royalties on franchise retail sales, and franchise fees. The Company's Manufacturing/Wholesale segment is comprised of its manufacturing operations in South Carolina and its wholesale sales business. This segment supplies its Retail and Franchise segments as well as various third parties with finished products. Its proprietary brands include Mega Men, Ultra Mega, WELLbeING, Pro Performance and Pro Performance AMP. The Company operates over 7000 GNC specialty retail stores. The Company's growth strategy includes growing company-owned domestic retail earnings, domestic square footage, and international footprint, expanding its e-commerce business and leveraging the GNC brand.
Company Website
SEC Reports
Industry: Pharmaceutical Retailers
Compare:
Traded in other countries:IGN.Germany
ยป More Articles for GNC

Headlines

Articles On GuruFocus.com
Top 5 Stocks from TPG-Axon Mar 21 2013 
Billionaire Steven Cohen Vitamins Up with GNC Mar 04 2013 
Generac Holdings: Umbrellas Sell Better on and After Rainy Days Nov 28 2012 
President and CEO of GNC Holdings Inc. Joe Fortunato Sold 50,000 Shares Aug 08 2012 
Weekly CFO Sells Highlight: USB, GNC, WWWW, GWRE, CRIS, CSL Apr 30 2012 
George Soros Buys 7.98% Stake in Digital River, Steven Cohen Buys 5.4% Stake in GNC Mar 30 2012 
Weekly CEO Sells Highlight: GNC Holdings, Prologis Inc, Intuit Inc, and Blackrock Inc. Feb 26 2012 
Stocks with Bigest Insider Buys and Sells November 2011 Dec 01 2011 
Top 5 Stocks with More Than $5 Million CEO Insider Sales Nov 02 2011 


Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial